Literature DB >> 8438049

Pleural involvement in the carcinoid syndrome.

S F Moss1, P J Lehner, S G Gilbey, A Kennedy, J M Hughes, S R Bloom, H J Hodgson.   

Abstract

Tissue fibrosis is a recognized complication of the carcinoid syndrome but pleural changes have not been described. Prompted by the finding of severe pleural thickening in two patients with the metastatic carcinoid syndrome but no thoracic metastases or previous pleural disease we reviewed the chest radiographs and CT scans in 50 patients with the carcinoid syndrome investigated from 1981 to 1990. Pleural abnormality was noted in 14 of the 50 patients (28%), five of whom had other possible causes for pleural disease. However, nine (18%) patients had 'idiopathic' pleural thickening. Pleural disease had developed within 2 years of the diagnosis in all cases, and seven of the nine patients had fibrosis elsewhere (heart valves, skin or mesentery). There were no features to suggest a more rapid disease progression in the patients with pleural disease. We suggest that the pleural abnormality is a complication of metastatic carcinoid disease.

Entities:  

Mesh:

Year:  1993        PMID: 8438049

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  4 in total

Review 1.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

Review 2.  Complications from carcinoid syndrome: review of the current evidence.

Authors:  José Mauricio Mota; Luana Guimarães Sousa; Rachel P Riechelmann
Journal:  Ecancermedicalscience       Date:  2016-08-08

Review 3.  Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome.

Authors:  Dominique Clement; John Ramage; Raj Srirajaskanthan
Journal:  J Oncol       Date:  2020-01-21       Impact factor: 4.375

Review 4.  Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications.

Authors:  Giovanni Vitale; Alessia Cozzolino; Pasqualino Malandrino; Roberto Minotta; Giulia Puliani; Davide Saronni; Antongiulio Faggiano; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.